Monkeypox Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Monkeypox stocks.

Monkeypox Stocks Recent News

Date Stock Title
May 3 SIGA Siga Technologies (SIGA) Upgraded to Strong Buy: Here's What You Should Know
May 3 SIGA Best Value Stocks to Buy for May 3rd
May 2 SIGA Siga Technologies Inc. (SIGA) Rises Higher Than Market: Key Facts
May 2 EBS Q1 2024 Emergent BioSolutions Inc Earnings Call
May 2 EBS Emergent BioSolutions Inc. (NYSE:EBS) Q1 2024 Earnings Call Transcript
May 2 CMRX Chimerix, Inc. (NASDAQ:CMRX) Q1 2024 Earnings Call Transcript
May 2 EBS Why Aspen Aerogels Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket
May 2 EBS Emergent BioSolutions gains as results top estimates, co to cut 300 jobs
May 2 EBS Emergent BioSolutions Inc (EBS) (Q1 2024) Earnings Call Transcript Highlights: A Strong Start ...
May 2 CMRX Chimerix Inc (CMRX) Q1 2024 Earnings Call Transcript Highlights: Strategic Developments and ...
May 2 EBS PRESS DIGEST- Wall Street Journal - May 2
May 2 CMRX Q1 2024 Chimerix Inc Earnings Call
May 2 EBS Emergent BioSolutions (EBS) Q1 2024 Earnings Call Transcript
May 2 EBS Emergent BioSolutions Inc. (EBS) Q1 2024 Earnings Call Transcript
May 2 EBS Emergent BioSolutions Inc. 2024 Q1 - Results - Earnings Call Presentation
May 1 EBS Emergent BioSolutions Reports Surprising Q1 2024 Earnings, Exceeding Revenue and Net Income ...
May 1 EBS Narcan-Maker Emergent BioSolutions to Cut 300 Jobs, Close Facilities
May 1 EBS Emergent Biosolutions Non-GAAP EPS of $0.59 beats by $1.45, revenue of $300.4M beats by $75.9M
May 1 SIGA SIGA Technologies to Host Business Update Call on May 7 Following Release of First-Quarter 2024 Financial Results
May 1 EBS Emergent BioSolutions Reports First Quarter 2024 Financial Results
Monkeypox

Monkeypox is an infectious disease caused by the monkeypox virus that can occur in certain animals, including humans. Symptoms begin with fever, headache, muscle pains, swollen lymph nodes, and feeling tired. This is followed by a rash that forms blisters and crusts over. The time from exposure to onset of symptoms is usually 7 to 14 days. The duration of symptoms is typically two to four weeks.Monkeypox may be spread from handling bushmeat, an animal bite or scratch, body fluids, contaminated objects, or close contact with an infected person. The virus normally circulates among certain rodents. Diagnosis can be confirmed by testing a lesion for the virus's DNA. The disease can appear similar to chickenpox.The smallpox vaccine can prevent infection with 85% effectiveness. In 2019, a monkeypox vaccine, Jynneos, was approved for adults in the United States. The current standard for treatment is tecovirimat, an antiviral that is specifically intended to treat infections with orthopoxviruses such as smallpox and monkeypox. It is approved for the treatment of monkeypox in the European Union and the United States. Cidofovir or brincidofovir may also be useful. Reports of the risk of death, if untreated, are as high as 10% to 11% in the Congo Basin (Central African) clade of monkeypox.Monkeypox was first identified in 1958 among laboratory monkeys in Copenhagen, Denmark. Monkeys are not a natural reservoir of the virus. The first cases in humans were found in 1970 in the Democratic Republic of the Congo. An outbreak that occurred in the United States in 2003 was traced to a pet store where rodents imported from Ghana were sold. The 2022 monkeypox outbreak represents the first incidence of widespread community transmission outside of Africa, which began in the United Kingdom in May 2022, with subsequent cases confirmed in at least 12 countries, including several in Europe, North America, as well as Australia and Israel.

Browse All Tags